Helping Life Science and Healthcare Companies Achieve Growth Objectives

Growth Capital for Life Sciences and Healthcare

Telegraph Hill Partners, founded in 2001, is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to efficiently drive growth and profitability while maintaining the vision and integrity of the organization.

"We seek to partner with innovative companies by providing capital and strategic guidance to help them become world-class businesses.”

THP Focus & Strategy

We partner with private life science and healthcare companies that have novel technologies, a solid customer base, and innovative management teams. We make investments into high-quality companies looking for capital to help build and grow their organizations. We encourage you to contact us to learn more about Telegraph Hill Partners.

Latest News & Announcements

View All

August 23, 2023

Cell Microsystems Acquires Fluxion Biosciences to Broaden Cell Analysis Product and Services Portfolio

Positions the Company as a new leader in providing solutions that bridge the gap between cellular electrophysiology and advanced analysis

March 15, 2023

Panome Bio Raises Growth Capital From Telegraph Hill Partners To Expand Next-Generation Metabolomics & Proteomics Business

ST. LOUIS, March 15, 2023 /PRNewswire/ — Panome Bio, a metabolomics and proteomics services company that provides biopharma innovators unparalleled

January 9, 2023

QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies

VENLO, The Netherlands & SAN DIEGO–(BUSINESS WIRE)– QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) today announced it has completed the acquisition of

Phone

415.765.6980

Email

info@thpartners.net

Address

300 Montgomery Street
Suite 1130
San Francisco, CA 94104